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Abstract The aims of this study are to assess patients’ pre-
ferred and perceived decision-making roles and preference
matching in a sample of German breast and colon cancer
patients and to investigate how a shared decision-making
(SDM) intervention for oncologists influences patients’ pre-
ferred and perceived decision-making roles and the attainment
of preference matches. This study is a post hoc analysis of a
randomised controlled trial (RCT) on the effects of an SDM
intervention. The SDM intervention was a 12-h SDM training
program for physicians in combination with decision board
use. For this study, we analysed a subgroup of 107 breast and
colon cancer patients facedwith serious treatment decisionswho
provided data on specific questionnaires with regard to their
preferred and perceived decision-making roles (passive, SDM
or active). Patients filled in questionnaires immediately follow-
ing a decision-relevant consultation (t1) with their oncologist.
Eleven of these patients’ 27 treating oncologists had received the
SDM intervention within the RCT. Amajority of cancer patients
(60%) preferred SDM. A match between preferred and
perceived decision-making roles was reached for 72% of pa-
tients. The patients treated by SDM-trained physicians perceived
greater autonomy in their decision making (p < 0.05) with more
patients perceiving SDM or an active role, but their preference
matching was not influenced. A SDM intervention for oncolo-
gists boosted patient autonomy but did not improve preference
matching. This highlights the already well-known reluctance of
physicians to engage in explicit role clarification.
Trial Registration: German Clinical Trials Register
DRKS00000539; Funding Source: German Cancer Aid.
Keywords Shared decisionmaking (SDM) . Preference
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Introduction
Most cancer patients prefer collaborative roles with their on-
cologists in treatment decision making [9]. However, there is
evidence that patients persistently experience less involve-
ment in the decision-making process than they would like
[3, 5, 17, 18, 22, 24, 31], and this mismatch has been linked
to adverse patient outcomes such as anxiety, dissatisfaction,
and decision regret [16, 18, 21, 24].
At least three approaches to medical decision making
in which patients and physicians play different roles and
that vary with regard to degree of patient autonomy have
been described in the literature [7, 8, 12]. The shared
decision-making (SDM) model, characterised by an inter-
mediate degree patient autonomy, has been referred to as
the Bcollaborative^ model. Under the SDM model, both
the patient and physician are actively involved in deciding
on a plan of treatment: they exchange information,
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address expectations, concerns and fears, deliberate on
treatment and role preferences, and finally arrive at a joint
decision [7, 8, 12]. Another model is the paternalistic
model, characterised by the lowest possible degree of pa-
tient autonomy. This model has been referred to as the
Bpassive^ or Bdoctor-directed^ model because, under this
approach, the physician alone decides, conveys his treat-
ment decision to the patient, and thus takes sole respon-
sibility for the treatment plan. The final model is the in-
formation model (or consumer model), which involves the
highest possible degree of patient autonomy. Under this
model, the patient is the sole independent and responsible
decision maker, making decisions after receiving com-
plete medical information from the physician. This model
has been referred to as the Bactive^ or Bpatient-directed^
model.
Studies of cancer patients’ decision-making preferences
generally report the highest preferences for SDM [5, 9, 16,
18, 24, 30], and the desire for this approach to decision mak-
ing has increased over the last three decades [9]. Two authors
have closely analysed the decision-making preferences and
experiences of cancer patients in the German healthcare set-
ting [15, 16, 33]. In contrast to international studies, the find-
ings of Vogel et al. [33] suggest that paternalism is more wide-
ly accepted among German patients and that SDM appears to
be rare in the initial treatment of breast cancer patients. Ernst
et al. [15] surveyed 533 German cancer patients, finding vary-
ing preferences with respect to participation, depending on the
issue at hand. Patients who reached a preference match and
those who were over-involved reported the highest satisfac-
tion levels.
Because international evidence strongly supports the ben-
efits and popularity of SDM, physicians have been encour-
aged to involve patients in their treatment decisions. It is rec-
ommended that physicians assess patients’ preferences with
respect to participation and match their consultation approach
to these preferences [25, 28, 29]. However, it is extremely
challenging for physicians to flexibly match their consultation
styles to the decision-making preferences of individual pa-
tients. The percentage of patients who fulfil their desired role
in decision making ranges from 34 to 80% [22, 25, 29].
Mismatches are most often found among patients who feel
less involved than they wish to be. Therefore, several authors
have called for communication training programs that teach
physicians SDM and preference assessment skills [17, 25, 33].
A framework for teaching and learning SDM involving sev-
eral steps has been proposed and should ideally be followed
[13, 32]. One of these steps—referred to as role clarification—
is to explicitly assess patients’ preferences with respect to their
roles in the decision-making process. Physicians who have
received SDM training should thus be able to better match
their consultation style to the decision-making preferences of
individual patients.
To date, the influence of an SDM training program on
patients’ perceived decision-making roles and the
achievement of preference matching has not been thor-
oughly examined. The International Breast Cancer Study
Group recently assessed the effects of a 7-h physician
communication training program that focuses on SDM
in a large patient sample (n = 683) [3], finding a desire
for more involvement in decision making among the
training group than the control group, although the differ-
ence was not statistically significant.
In summary, several studies have underscored physicians’
shortcomings in involving cancer patients in medical decision
making and in matching their consultation style to patients’
desired levels of autonomy, but benefits for patients
can be expected under both approaches. The situation for
cancer patients in Germany appears to be even more desper-
ate. In light of these findings, we explored the following
questions:
1. How are patients’ preferred and perceived decision-
making roles distributed among a sample of German
breast and colon cancer patients?
2. How many cancer patients attain a preference match?
3. How does an SDM training intervention for oncologists
influence patients’ preferred and perceived decision-
making roles and the attainment of a preference match?
Methods
The participants were a subgroup of 86 physicians and their
160 patients with breast or colon cancer who participated in a
prospective parallel-group cluster RCT and provided data on
specific questionnaires relevant for the analysis reported in
this paper. The study reported here is a post hoc analysis of
the RCT. Detailed results of the RCT as well as recruitment
methods and procedures are reported elsewhere [19] and will
therefore only be summarised. In the RCT, patient-reported
outcomes and observer-rated measures (OPTION) of an inter-
vention group (IG) (SDM intervention for physicians) and a
control group (CG) (treatment as usual) were compared. The
main result of the RCT was that SDM-trained IG physicians
showed higher competence than their non-trained counter-
parts in observer-rated SDM skills (Cohen’s d = 0.56;
p < 0.05). Patients treated by trained physicians had lower
anxiety and depression scores immediately after the consulta-
tion (d = −0.12 and −0.14, respectively; p < 0.10), and mark-
edly lower anxiety and depression scores 3 months later
(d = −0.94 and −0.67, p < 0.01). The ethics committees of
the University of Heidelberg, Germany, and the University of




In total, 86 physicians participated in the RCT and were
randomised to IG or CG. However, 53 physicians dropped
out from the study due to organisational barriers like job rota-
tions and time constraints before recruiting any patients. Six
more physicians were excluded from the analysis because
their patients did not provide valid data on the Control
Preferences Scale (CPS) or the Patient Perception Scale
(PPS). Thus, the analysis included 27 physicians, 11 of whom
(40.7%) had been trained in SDM (IG). The physicians’ ages
ranged from 26 to 58 years (M = 37.44, SD = 7.81), and their
professional experience ranged from 6 months to 30 years
(M = 9.72, SD = 7.16). Fifteen of the 27 physicians (55.6%)
were male. Twenty-four physicians (88.9%) worked in an in-
patient setting. Themajority of physicians (n = 21, 77.8%) had
no training in psychosomatics.
Patients
In total, 160 patients with breast or colon cancer faced with a
serious treatment decision (i.e., decision for or against adju-
vant chemotherapy in patients with colon cancer stage II with
risk factors or decision for mastectomy or lumpectomy and
radiation in early-stage breast cancer) participated in the RCT.
The patients’ socio-demographic and clinical characteristics
are summarised in Table 1. Fifty-three patients were eliminat-
ed from the analysis because they did not provide data on the
CPS or PPS. Significantly more females than males did not
complete the CPS (χ2(1, N = 133) = 4.41, p = .04). There
were no other significant differences with respect to
socio-demographic characteristics between those who com-
pleted the CPS or PPS and were analysed and those who were
eliminated from the study prior to the analysis. Of the 107
patients included in the analysis, 93 were inpatients (86.9%).
Of these, 78.5% (n = 84) were women. The patients’ ages
ranged from 25 to 88 years (M = 63.78; SD = 13.51). The
majority of the patients had early-stage disease, and the most
common diagnosis was breast cancer (54.2%).
Procedure
After consenting to participate in the study, the physicians
completed a questionnaire on their socio-demographic and
work-related characteristics and were randomly allocated to
the IG or CG. Physicians in the IG received 12 h of SDM
training that included risk communication and the use of de-
cision boards [19] before starting patient recruitment. The CG
physicians immediately started patient recruitment. As an in-
centive to participate in the study, the CG physicians were
offered SDM training after completion of the RCT. Each
physician was asked to include eight patients in the study.
The patients were informed about the study by their physician,
received written study information, and signed informed con-
sent forms. After the initial consultation, which was
audio-taped by the physician, the patients were asked to di-




The patients’ role preferences for involvement in the decision-
making process were assessed using the Control Preferences
Scale (CPS) [11]. The patients were asked to indicate how they
would like their treatment decisions to be made. Response op-
tions included the following: (a) BI prefer to make the final
treatment decision^; (b) BI prefer to make the final treatment
decision after seriously considering my doctor’s opinion^; (c)
BI prefer that my doctor and I share responsibility for deciding
which treatment is best^; (d) BI prefer that my doctor makes the
final treatment decision but seriously considers my opinion^;
Table 1 Socio-demographic and clinical characteristics of the patient
sample (N = 107)
Control group
(n = 71), n (%)
Intervention
group
(n = 36), n (%)
Total
(N = 107), n (%)
Sex
Male 12 (16.9) 11 (30.6) 23 (21.5)
Female 50 (82.0) 25 (69.4) 84 (78.5)
Age (years)
Mean (SD) 64.0 (12.4) 63.4 (15.6) 63.8 (13.5)
Family status
Never married 7 (7.0) 2 (5.6) 7 (6.5)
Married 44 (62.0) 25 (69.4) 68 (63.6)
Divorced 8 (11.3) 3 (8.3) 11 (10.3)
Widowed 14 (19.7) 6 (16.7) 20 (18.7)
Formal education
Below 12 years 61 (85.9) 33 (91.7) 94 (87.9)
12 years or
more
9 (12.7) 3 (8.3) 12 (11.2)
Cancer type
Breast 44 (62.0) 14 (38.9) 58 (54.2)
Colon 27 (38.0) 22 (61.1) 49 (45.8)
Cancer stage
I 18 (25.4) 9 (25.0) 27 (25.2)
II 17 (23.9) 10 (27.8) 27 (25.2)
III 24 (33.8) 10 (27.8) 34 (31.8)
IV 8 (11.3) 4 (11.1) 12 (11.2)
Cells not adding up to column sums indicate missing values; valid relative
frequencies are reported
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and (e) BI prefer to leave all treatment decisions to my doctor .^
In the analyses, the responses were collapsed into three catego-
ries to reflect a paternalistic/passive approach (options d and e),
an SDM/collaborative approach (option c) and an information
model/active approach (options a and b) [11].
Patient Perception Scale
The patients’ role perceptions in the decision-making process
were assessed using adaptations of the above noted items from
the CPS in which patients indicated their perceptions of what
actually occurred in the consultation [23]. In this Patient
Perception Scale (PPS) they could again choose from five
statements that described how the decision was made, e.g.,
BMy doctor and I shared responsibility for deciding which
treatment was best for me^. For the purposes of the analyses,
the five categories were again collapsed into the three
abovementioned categories (see also [10, 27]).
Preference Match
To describe how a patient’s perceived decision-making role
(PPS) [23] accorded with his/her preferred decision-making
role (CPS) [11], a new variable, indicating three levels of
congruence, was created from the responses to the PPS and
CPS: (1) the patient participated in the decision at a level that
was less than he/she preferred (under-involved); (2) the pa-
tient’s experience was concordant with his/her preference
(successful match); (3) the patient participated in the decision
at a higher level that he/she preferred (over-involved).
Data Analysis
Descriptive statistics (frequencies and percentages) were used
to describe socio-demographic, disease-related (patients) and
work-related (physicians) data, role preferences, and perceived
roles. Usingχ2 tests, the proportions of patients were compared
with respect to their answers to questions regarding decision-
making roles. Differences between the IG and CG with respect
to patients’ preferred and perceived decision-making roles and
preference matching were also assessed using χ2 tests.
Results
Preferred and Perceived Decision-Making Roles
Figure 1 presents the patients’ decision-making preferences
and experiences. We found that 59.8% (n = 64) of all breast
and colon cancer patients preferred to share treatment deci-
sions with their physicians. Additionally, 20.6% (n = 22) of
patients wished to make the treatment decision on their own,
and 19.6% (n = 21) of patients preferred that the physician
make the treatment decision. More than half of the patients
(51.5%, n = 50) reported that the actual decision making was
shared (SDM), 24.7% (n = 24) reported an active decision-
making experience (information model), and 23.7% (n = 23)
reported that the decision-making was physician-directed
(paternalism).
Match of Preferred and Perceived Decision-Making Roles
Ninety-six patients provided data on both the CPS and PPS
(see Table 2). Of these, 71.9% (n = 69) reported a match
between their preferred and perceived decision-making ap-
proaches (Table 2 diagonal), 13.5% (n = 13) felt that they
had been less involved than they preferred, and 14.6%
(n = 14) felt more involved than they preferred.
Influence of a Shared Decision-Making Training
Intervention for Physicians on Patients’ Preferred
and Perceived Decision-Making Roles and on Preference
Matching
Preferred and perceived decision-making roles of IG and CG
patients are presented in Fig. 2. Chi-squared analyses show
significant group differences in the PPS (χ2(2, N = 97) = 7.93,
p = 0.019), with CG patients more likely than IG patients to
experience paternalism (paternalism IG: n = 3 (8.3%) vs. CG:
n = 20 (32.8%) and with IG patients more likely than CG
patients to experience SDM (IG: n = 21 (58.3%) vs. CG:
n = 29 (47.5%)) or information model (IG: n = 12 (33.3%)
vs. CG: n = 12 (19.7%). Additionally, 72% (n = 44) of CG
patients and 71% (n = 25) of IG patients achieved their pre-
ferred level of involvement. There were no significant group
differences neither on the CPS (χ2(2, N = 107) = 1.45,
p = 0.485) no r on pre fe r ence match ing (χ 2 (2 ,
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Fig. 1 Distribution of cancer patients’ decision-making preferences and
perceptions: patients’ preferred decision-making roles (n = 107) and
patients’ perceived decision-making roles (n = 97) in percentages
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Discussion
In this study, we assessed a sample of 107 German breast and
colon cancer patients faced with serious treatment decisions
with regard to preferred and perceived roles in medical deci-
sionmaking and successful preferencematching. In particular,
we assessed the influence of an SDM intervention on these
three variables.
The study’s first main finding is that the desire for SDMwas
predominant among surveyed German cancer patients, with
60% of patients opting for a collaborative SDM approach with
their physician independent of the group condition (IG vs. CG).
These findings indicate that involvement in treatment decision
making is a development welcomed by cancer patients in
Germany, a conclusion that contrasts with the findings of
Vogel et al. [33], who reported the predominance of passive
role preferences (40%) in a sample of newly diagnosed
German breast cancer patients. While 29% of patients in their
sample preferred SDM, only 13% reported having experienced
SDM. Vogel et al. [33] suspected that cultural differences and
characteristics of German health services explained their find-
ings, as these findings contrast with those of other international
studies [5, 9, 22, 23, 26], which have reported higher
involvement preferences. Another assessment of German can-
cer patients [15] produced findings closer to international sam-
ples. However, Vogel et al. [33] concluded that SDM is rare in
initial treatments of breast cancer patients in Germany. In our
study, even in the control group, 42% of patients felt after con-
sultation that SDM has been achieved. This finding casts a
more favourable light on the practice and on the ability of
German oncologists to involve their patients in treatment deci-
sion making. One possible reason for the higher patient in-
volvement documented in our sample may be the physicians’
awareness of patient involvement as the focus of our study,
which may have resulted in a high motivation to comply with
this aim. Another reason may relate to a time trend reported in a
review [9] showing that the number of patients preferring a
collaborative SDM approach has increased internationally over
the past three decades. This time trend may follow a different
dynamic in Germany, where it may have started later and in-
creased at a fast pace, thanks to a decade of substantial advances
in German health policy that have fostered increased
socio-political acceptance of SDM [20].
The study’s second main finding is that matching of pa-
tients’ preferred and perceived decision-making styles was
achieved for 72% of the cancer patients in our sample.
Table 2 Patients’ preferred and
perceived decision-making roles
and their match or mismatch
Perceived decision-making role (post-consultation)
Paternalistic model SDM Information model Totals
Preferred decision-making role
(post-consultation)
n % n % n % N %
Paternalistic model 13 13.5 3 3.1 4 4.2 20 20.8
SDM 8 8.3 43 44.8 7 7.3 58 60.4
Information model 2 2.1 3 3.1 13 13.5 18 18.8
Totals 23 24.0 49 51.0 24 25.0 96 100.0
More involvement than preferred above diagonal: 14 patients, 14.6%. Less involvement than preferred below
diagonal: 13 patients, 13.5%. Bold indicates preference match. Missing n = 11 (10.3%)
SDM shared decision-making
Fig. 2 Influence of SDM
intervention on patients’ decision-
making preferences and
perceptions: patients’ preferred
decision-making roles (n = 107)
and patients’ perceived decision-
making roles (n = 97) in the
control group (CG) and the
intervention group (IG) in
percentages
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Patients whose preferences were not met reported either being
more involved (15%) or less involved (14%) than they wished
to be. This rate of preference matching is at the upper end of
the spectrum found in most studies that have investigated this
issue; previously reported percentages have ranged between
34 and 80% [25]. For the two German samples, 44% [15] and
63% [33] of patients achieved a preference match. Our find-
ings might indicate that the physician sample in our study was
rather sensitive and skilled in matching their decision-making
style to their patients’ desired levels of participation.
The study’s third main finding is that the SDM intervention
was successful in boosting patient autonomy because it sig-
nificantly raised the extent of involvement patients experi-
enced in their consultations. Altogether, 92% of IG patients
perceived collaborative or active decision making, and only
8% experienced paternalism. In the CG, 67% of patients ex-
perienced some degree of involvement (collaborative or ac-
tive), and 33% reported paternalism. Thus, the Bbaseline^ lev-
el of involvement in the CG is already satisfactory.We assume
that study participation per se may have increased physicians’
awareness of the importance of patient involvement and may
have prompted them to facilitate patient involvement as best
they could. However, as we hoped to demonstrate, physicians
enrolled in SDM training showed higher involvement skills
than their counterparts not enrolled in SDM, skills that—be-
cause the design was randomised controlled—they must have
acquired during the training. In line with this result, findings
discussed in the RCT publication of the trial [19] show that
SDM-trained physicians demonstrated better observer-rated
SDM skills than the control physicians when audio-tapes of
the consultations were analysed using the OPTION instru-
ment. The International Breast Cancer Study Group recently
assessed the effects of a 7-h communication training program
for physicians, with a focus on SDM [3]. They found a trend
towards greater patient involvement in decision making in the
training group compared with the CG but no significant dif-
ferences. They concluded that their 7-h SDM training program
may not have been sufficiently intensive to produce
patient-related outcomes, as a dose-response effect is known
to generally characterise communication skills training.
However, our slightly more intensive SDM training program,
in combination with the use of decision boards, led to an
increase in patient autonomy, which suggests that a satisfac-
tory training dose for this purpose may be 12 h or more.
Contrary to expectations, we detected no influence of the
SDM intervention on preference matching. Irrespective of
whether an SDM intervention was administered, a preference
match was attained for approximately 72% of patients (IG
71%, CG 72%). Ideally, preference matching should have
been more common in the IG than in the CG because one of
the six steps of the SDM model [13] taught during training is
role clarification. However, CG and IG patients differed with
respect to unmet expectations. Specifically, CG patients might
have experienced more unwanted paternalism, while the IG
patients might have been pushed into an overly active role.
Our findings support the power of SDM training to strengthen
patient autonomy, but they also demonstrate a need to
intensify the module on eliciting patients’ preferred
decision-making roles and adhering to them. Indeed, in the
SDM training program, our trainers found that the physicians
felt uncomfortable in role playing when asked to engage in
explicit role clarification. The reluctance of physicians to en-
gage in explicit role clarification has been previously observed
[14]. Analyses of audio-taped consultations using the
observer-based OPTION scale found shortcomings among
nearly all physicians with respect to the SDM step of role
clarification (unpublished data). As a consequence, we will
revise the role clarification module of the SDM training pro-
gram for future use. However, we do not know if an un-
matched preference and perceived decision-making style lead
to a negative evaluation of the consultation by the patients.
Especially for patients who prefer SDM and perceive an
over-involvement (informationmodel), it might be considered
that a consultation in a SDM style supports the autonomy of
the patient in a way that the patient is comfortably able to
make a treatment decision without a recommendation of the
physician.
The study’s findings must be seen in light of some limita-
tions. Despite a sufficient number of participating physicians,
we failed to reach the targeted sample size for patients (eight
for each physician) in the RCT. We suspect that, among other
reasons, this relatively small patient pool relates to the de-
manding study procedures for the physicians and their reluc-
tance to audio-tape presumably imperfect consultations (also
see [19]). The small sample size of patients may have hindered
detection of small effects due to the underpowered nature of
the study. However, and because of this, the detected effects
can be considered all the more robust. Some of the effects
found in the study, such as the rather high involvement rates
and the high rates of preference matching attained, may result
from self-selection bias, with physicians who are open to the
SDM concept more likely to participate in the study [4].
Although study participation was usually imposed in a
top-down manner by the chief consultants of the whole phy-
sician team at the cancer centre, a consultant’s openness to
SDM may rub off on the whole team. Another weakness of
the study is the uneven allocation of patients to the IC and CG
treatments, with more than half allocated to the CG, impeding
subgroup analyses. This most likely occurred because CG
physicians could start patient recruitment immediately after
study inclusion and did not have to undergo SDM training
first. Additionally, Brown et al. [5] have shown that role pref-
erences may differ when they are assessed before and after the
consultation. Post-consultation preferences in their study were
more l ike ly to accord wi th pa t ien ts ’ perce ived
decision-making approach. In our study, we only assessed
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post-consultation role preferences of patients and may there-
fore have missed the share of patients who altered their pref-
erences post-consultation.
Future studies that assess cancer patients’ preferences and
perceptions of involvement should keep patient recruitment as
uncomplicated as possible for physicians to prevent high phy-
sician dropout rates.
Conclusion
The desire for involvement in treatment decision-making was
high in the sample of German breast and colon cancer patients
surveyed in this study, and 72% of the sample attained their
preferred role in decision making. The 12-h SDM training
program, in combination with use of decision boards, boosted
patient autonomy but did not lead to greater consideration of
patients’ individually preferred decision-making style. This
highlights the already well-known reluctance of physicians
to engage in explicit role clarification. Consideration of pa-
tients’ preferred decision-making style is of high importance;
however, when in doubt, physicians should offer SDM as the
safest alternative.
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